Late acute rejection after liver transplantation: The Western Canada experience

Liver Transplantation

Volumn 8, Issue 10, 2002, Pages 945-951

  Ramji, Alnoor ^a   Yoshida, Eric M ^a   Bain, Vincent G ^d   Kneteman, Norman M ^d   Scudamore, Charles H ^b   Ma, Mang M ^d   Steinbrecher, Urs P ^a   Gutfreund, Klaus S ^d   Erb, Siegfried R ^a   Partovi, Nilufar ^c   Chung, Stephen W ^b   Shapiro, James ^d   Wong, Winnie W S ^d  

^a Department of Medicine ^*  (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; STEROID; TACROLIMUS;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; CANADA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT REJECTION; GROUPS BY AGE; HEPATITIS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; POSTOPERATIVE PERIOD; PREDICTION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECIPIENT; REOPERATION; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0036793253     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2002.34969     Document Type: Article

References (27)

1. Smith CM. Liver transplantation in the United States: A report from the UNOS Liver Transplant Registry. Clin Transpl 1999: 23-34.
2. Mor E, Gonwa TA, Husberg BS, Goldstein RM, Klintmalm GB. Late-onset acute rejection in orthotopic liver transplantation-associated risk factors and outcome. Transplantation 1992;54: 821-824.
3. Klintmalm GB, Nery JR, Husberg BS, Gonwa TA, Tillery GW. Rejection in liver transplantation. Hepatology 1989;10:978-985.
4. Starzl TE, Koep LJ, Halgrimson C, Hood J, Schroter GP, Porter KA, Weil R 3rd. Fifteen years of clinical liver transplantation. Gastroenterology 1979;77:375-378.
5. Berlakovich GA, Rockenschaub S, Taucher S, Kaserer K, Muhlbacher F, Steiniger R. Underlying disease as a predictor for rejection after liver transplantation. Arch Surg 1998;133:167-172.
6. The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110-1115.
7. European FK506 Multicenter Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 1994;344:423-428.
8. Wiesner R, Rabkin J, Klintmalm G, McDiarmid S, Langnas A, Punch J, et al. A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients. Liver Transpl 2001;7:442-450.
9. Greig PD, Grant DR, Kneteman NR, McAlister VC, Scudamore CH, Roy AF, et al. Long-term results of early steroid withdrawal following liver transplantation [abstract]. Am J Transpl 2001; 1(suppl 1):418A.
10. Starzl TE, Demetris AJ, Trucco M, Ramos H, Zeevi A, Rudert WA, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992;340:876-877.
11. Mazariegos GV, Reyes J, Marino IR, Demetris AJ, Flynn B, Irish W, et al. Weaning of immunosuppression in liver transplant recipients. Transplantation 1997;63:243-249.
12. Yoshida EM, Shackleton CR, Erb SR, Mori LM, Ford JA, Eggen H, et al. Late acute rejection occurring in liver allograft recipients. Can J Gastroenterol 1996;10:376-380.
13. Samuel D, Gugenheim J, Canon C, Saliba F, Bismuth H. Use of OKT3 for late acute rejection in liver transplantation. Transplant Proc 1990;22:1767-1768.
14. Mor E, Solomon H, Gibbs JF, Holman MJ, Goldstein RM, Husberg BS, et al. Acute cellular rejection following liver transplantation: Clinical pathologic features and effect on outcome. Semin Liver Dis 1992;12:28-40.
15. Farges O, Sabila F, Farhamant H, Samuel D, Bismuth A, Reynes M, Bismuth H. Incidence of rejection and infection after liver transplantation as a function of the primary disease: Possible influence of alcohol and polyclonal immunoglobulins. Hepatology 1996;23:240-248.
16. Markus BH, Duquesnoy RJ, Gordon RD, Fung JJ, Vanek M, Klintmalm G, et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation 1988; 46:372-377.
17. O'Grady JG, Alexander GJ, Sutherland S, Donaldson PR, Harvey F, Portmann B, Calne RY. Cytomegalovirus infection and donor/recipient HLA antigens: Interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation. Lancet 1988;2:302-305.
18. Howard TK, Klintmalm GB, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990; 49:103-107.
19. Nikaein A, Backman L, Jennings L, Levy MF, Goldstein R, Gonwa T, et al. HLA compatibility and liver transplantation outcome. Improved patient survival and cross-matching. Transplantation 1994;58:786-792.
20. Demetris AJ, Seaberg EC, Batts KP, Ferrell LD; Ludwig J, Markin RS, et al. Reliability and predictive value of the NIDDK liver transplant database nomenclature and grading system for cellular rejection of liver allografts. Hepatology 1995;21:408-416.
21. Hubscher S. Histologic findings in liver allograft rejection-New insights into the pathogenesis of hepatocellular damage in liver allografts. Histopathology 1991;18:377-383.
22. Anand AC, Hubscher SG, Gunson BK, McMaster P, Neuberger JM. Timing, significance, and prognosis of late acute liver allograft rejection. Transplantation 1995;60:1098-1103.
23. Feray C, Zignego AL, Samuel D, Bismuth A, Reynes M, Tiollais P, et al. Persistent hepatitis B virus infection of mononuclear cells without concomitant liver infection: The liver transplantation model. Transplantation 1990;49:1155-1158.
24. Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, et al. Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients. Liver Transpl 2000;6: 553-561.
25. Fung JJ, Eliasziw M, Todo S, Jain A, Demetris AJ, McMichael JP, et al. The Pittsburgh randomized trial of tacrolimus compared with cyclosporine for hepatic transplantation. J Am Coll Surg 1996;183:117-125.
26. Dousset B, Hubscher SG, Padbury RT, Gunson BK, Buckels JA, Mayer AD, et al: Acute liver allograft rejection-Is treatment always necessary? Transplantation 1993;55:529-534.
27. Backman L, Gibbs J, Levy M, McMillan R, Holman M, Husberg B, et al. Causes of late graft loss after liver transplantation. Transplantation 1993;55:1078-1082.